August 29, 2024
(Reuters) – Merck has stopped two separate late-stage studies of its immunotherapy Keytruda in patients with skin and lung cancers, the company said on Thursday, marking […]
August 29, 2024
TOPLINE: The number of cancer cases in men is estimated to increase by 84% from 2022 to 2050 — reaching 19 million globally — and deaths […]
August 27, 2024
TOPLINE: About 90% of patients with advanced melanoma who had a complete response to first-line immune checkpoint inhibitors survived more than 3 years, with survival curves […]
August 27, 2024
TOPLINE: Higher mortality risks were associated with loneliness in cancer survivors in a new study. The authors concluded that screening for loneliness should be integrated into […]
August 23, 2024
A few years after moving with her family from Iraq to the United States, Areej El-Jawahri, MD, entered the University of Michigan with plans to study […]
August 23, 2024
TOPLINE: Spouses of patients with cancer face a significantly higher risk for suicide attempts and deaths, especially within the first year after their spouse is diagnosed […]
August 23, 2024
Adding baseline MRI to conventional prostate cancer risk stratification could improve prognostic accuracy, potentially affecting active surveillance and treatment decisions for some patients, according to the […]
August 23, 2024
Prior exposure to conventional irinotecan does not affect survival in patients with advanced pancreatic ductal adenocarcinoma (PDAC) who are subsequently treated with the liposomal formulation nanoliposomal […]
August 22, 2024
TOPLINE: In patients with small, peripheral non–small cell lung cancer (NSCLC), visceral pleural invasion leads to worse disease-free and recurrence-free survival as well as higher rates […]